1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kim, S.
Jao, S.
Laurence, J.S.
LiWang, P.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
40
10782
10791
10.1021/bi011065x
11535053
Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5.
2001
US
Biochemistry
BICHAW
0033
0006-2960
39
3401
3409
10.1021/bi9923196
CC chemokine MIP-1beta can function as a monomer and depends on Phe13 for receptor binding
2000
US
Science
SCIEAS
0038
0036-8075
263
1762
1767
High-resolution solution structure of the beta chemokine hMIP-1beta by multidimensional NMR
1994
10.2210/pdb1je4/pdb
pdb_00001je4
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
7748.646
macrophage inflammatory protein 1-beta
F13A
1
man
polymer
MIP-1beta, T-CELL ACTIVATION PROTEIN 2, ACT-2, LYMPHOCYTE ACTIVATION GENE-1 PROTEIN, LAG-1
no
no
APMGSDPPTACCASYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN
APMGSDPPTACCASYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
plasmid
pET32
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-10-03
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
1HUM is the dimeric MIP-1beta wild-type protein.
1VMP binds to CCR5 which is a natural receptor of MIP-1beta.
RCSB
Y
RCSB
2001-06-15
REL
REL
This structure was determined using standard 3D 15N or 13C edited NMR experiments.
1
3D_13C-separated_NOESY
3D_15N-separated_NOESY
HNHA
20mM sodium phosphate
2.5
ambient
298
K
The structure is based on a total 940 restraints, 851
distance constraints, 69 dihedral angle restraints, 20 distance restraints for 10 hydrogen bonds.
The initial fold was obtained by distance geometry and further refined by simulated annealing.
minimized average structure
1-2mM MIP-1b F13A U-15N, 13C; 20mM Na-phosphate buffer
90% H2O/10% D2O
Delaglio
processing
NMRPipe
Brunger
structure solution
CNS
1.0
Brunger
refinement
CNS
1.0
500
Varian
INOVA
600
Varian
INOVA
ALA
1
n
1
ALA
1
A
PRO
2
n
2
PRO
2
A
MET
3
n
3
MET
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
ASP
6
n
6
ASP
6
A
PRO
7
n
7
PRO
7
A
PRO
8
n
8
PRO
8
A
THR
9
n
9
THR
9
A
ALA
10
n
10
ALA
10
A
CYS
11
n
11
CYS
11
A
CYS
12
n
12
CYS
12
A
ALA
13
n
13
ALA
13
A
SER
14
n
14
SER
14
A
TYR
15
n
15
TYR
15
A
THR
16
n
16
THR
16
A
ALA
17
n
17
ALA
17
A
ARG
18
n
18
ARG
18
A
LYS
19
n
19
LYS
19
A
LEU
20
n
20
LEU
20
A
PRO
21
n
21
PRO
21
A
ARG
22
n
22
ARG
22
A
ASN
23
n
23
ASN
23
A
PHE
24
n
24
PHE
24
A
VAL
25
n
25
VAL
25
A
VAL
26
n
26
VAL
26
A
ASP
27
n
27
ASP
27
A
TYR
28
n
28
TYR
28
A
TYR
29
n
29
TYR
29
A
GLU
30
n
30
GLU
30
A
THR
31
n
31
THR
31
A
SER
32
n
32
SER
32
A
SER
33
n
33
SER
33
A
LEU
34
n
34
LEU
34
A
CYS
35
n
35
CYS
35
A
SER
36
n
36
SER
36
A
GLN
37
n
37
GLN
37
A
PRO
38
n
38
PRO
38
A
ALA
39
n
39
ALA
39
A
VAL
40
n
40
VAL
40
A
VAL
41
n
41
VAL
41
A
PHE
42
n
42
PHE
42
A
GLN
43
n
43
GLN
43
A
THR
44
n
44
THR
44
A
LYS
45
n
45
LYS
45
A
ARG
46
n
46
ARG
46
A
SER
47
n
47
SER
47
A
LYS
48
n
48
LYS
48
A
GLN
49
n
49
GLN
49
A
VAL
50
n
50
VAL
50
A
CYS
51
n
51
CYS
51
A
ALA
52
n
52
ALA
52
A
ASP
53
n
53
ASP
53
A
PRO
54
n
54
PRO
54
A
SER
55
n
55
SER
55
A
GLU
56
n
56
GLU
56
A
SER
57
n
57
SER
57
A
TRP
58
n
58
TRP
58
A
VAL
59
n
59
VAL
59
A
GLN
60
n
60
GLN
60
A
GLU
61
n
61
GLU
61
A
TYR
62
n
62
TYR
62
A
VAL
63
n
63
VAL
63
A
TYR
64
n
64
TYR
64
A
ASP
65
n
65
ASP
65
A
LEU
66
n
66
LEU
66
A
GLU
67
n
67
GLU
67
A
LEU
68
n
68
LEU
68
A
ASN
69
n
69
ASN
69
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
29
A
O
TYR
29
A
N
VAL
41
A
N
VAL
41
A
N
VAL
40
A
N
VAL
40
A
O
ALA
52
A
O
ALA
52
1
A
ASP
6
-147.62
58.19
1
A
ALA
10
-165.58
32.26
1
A
ALA
17
-97.14
37.86
1
A
PHE
24
-97.26
30.74
1
A
VAL
26
-90.03
-64.25
1
A
SER
32
-60.33
-170.09
1
A
ASP
53
-57.79
109.08
minimized average
Solution structure of the monomeric variant of the chemokine MIP-1beta
1
N
N
A
PRO
21
A
PRO
21
HELX_P
A
ASN
23
A
ASN
23
5
1
3
A
GLU
56
A
GLU
56
HELX_P
A
LEU
68
A
LEU
68
1
2
13
disulf
2.030
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.031
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
51
A
SG
CYS
51
1_555
ANTIVIRAL PROTEIN
MIP-1beta, chemokine, macrophage inflammatory protein, ANTIVIRAL PROTEIN
CCL4_HUMAN
UNP
1
24
P13236
APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN
24
92
1JE4
1
69
P13236
A
1
1
69
1
PHE
engineered mutation
ALA
13
1JE4
A
P13236
UNP
36
13
3
anti-parallel
anti-parallel
A
VAL
25
A
VAL
25
A
GLU
30
A
GLU
30
A
VAL
40
A
VAL
40
A
THR
44
A
THR
44
A
CYS
51
A
CYS
51
A
ALA
52
A
ALA
52